Dylan E. Jones, PhD, was born and raised in northern Minnesota but a passion for mountains and chemistry has kept him out west. He received his BA from Concordia College in Moorhead, Minnesota, in 2014 and joined the Department of Chemistry at the University of Nevada Reno as a graduate student the same year. During his graduate studies, Jones also researched as a visiting scholar at the Katholieke Universiteit Leuven in Leuven, Belgium, on two occasions.
In 2019, Jones was awarded his PhD following the successful completion of his dissertation entitled "Synthesis & Pharmacokinetic Evaluation of Cyclotriazadisulfonamide (CADA) Analogs to Target Signal Peptides." From 2019-2022, Jones was a postdoctoral scholar in the Department of Biochemistry & Molecular Biology at the University of Nevada Reno in the lab of Robert O. Ryan, PhD, where he published several papers on the biochemistry underlying impaired mitochondria function in an effort to predict molecular "biomarkers" that may help predict and diagnose various diseases including cardiac disease.
Jones teaches biochemistry lecture and lab, organic chemistry lab and general chemistry lecture. In each of these courses, Jones strives to guide students to develop a chemical intuition that can be applied to the endless chemical reactions they will encounter as chemists. He believes the most effective approach to teaching includes empathy, patience and respect.
Outside of his work at CMU, Jones can typically be found outside enjoying numerous activities such as backpacking, fly fishing, climbing, trail running, hiking and biking.
Selected Published Work
Jones, D. E.; Jennings, E. A.; Ryan, R. O. (2022) Diversion of acetyl CoA to 3- methylglutaconic acid caused by discrete inborn errors of metabolism. Metabolites 12(5), 337.
Jones, D. E.; Romenskaia, I.; Kosma, D. K.; Ryan, R. O. (2022) Role of non-enzymatic chemical reactions in 3-methylglutaconic aciduria. FEBS J. 289(10), 2948-2958.
Jones, D. E.; Klackling, E.; Ryan, R. O. (2021) Inborn errors of metabolism associated with 3-methylglutaconic aciduria. Clinica Chimica Acta 522, 96-104.
Jones, D. E.; Ricker, J. D.; Geary, L. M.; Kosma, D. K.; Ryan, R. O. (2021) Isomerization of trans-3-methylglutaconic acid. JIMD Reports 58(11), 61-69.
Young, R.; Jones, D. E.; Diacovich, L.; Witkowski, A.; Ryan, R. O. (2020) trans-3- methylglutaconyl CoA isomerization-dependent protein acylation. Biochem. Biophys. Res. Commun. 534, 261-265.
Jones, D. E.; Perez, L.; Ryan, R. O. (2019) 3-Methylglutaric acid in energy metabolism. Clinica Chimica Acta 502, 233-239.
Berger, K.; Pauwels, E.; Parkinson, G.; Landberg, G.; Le, T.; Demillo, V. G.; Lumangtad, L. A.; Jones, D. E.; Islam, M. A.; Olsen, R.; Kapri, T.; Intasiri, A.; Vermeire, K.; Rhost, S.; Bell, T. W. (2021) Reduction of progranulin-induced breast cancer stem cell propagation by sortilin-targeting cyclotriazadisulfonamide (CADA) compounds. J. Med. Chem. 64(17), 12865-12876.
Ali, R.; Anugu, S.; Chawla, R.; Demillo, V. G.; Goulinet-Mateo, F.; Hamal, S.; Jones, D. E.; Lamprecht, K.; Le, T.; Lumangtad, L. A.; Plflug, N. C.; Sama, A.; Scarbrough, E. D.; Bell, T.W. (2019) Tsuji-Trost cyclization of disulfonamides; Synthesis of 12- membered, 11-membered, and pyridine-fused macrocyclic triamines. ACS Omega 4, 1254-1264.